Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

2.9%

1 terminated/withdrawn out of 35 trials

Success Rate

94.7%

+8.2% vs industry average

Late-Stage Pipeline

31%

11 trials in Phase 3/4

Results Transparency

28%

5 of 18 completed trials have results

Key Signals

2 recruiting5 with results

Enrollment Performance

Analytics

Phase 1
11(34.4%)
Phase 3
8(25.0%)
Phase 2
7(21.9%)
N/A
3(9.4%)
Phase 4
3(9.4%)
32Total
Phase 1(11)
Phase 3(8)
Phase 2(7)
N/A(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (35)

Showing 20 of 35 trials
NCT06564194Phase 1Active Not Recruiting

A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV

Role: collaborator

NCT06581575Phase 2Active Not Recruiting

A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine

Role: collaborator

NCT05136664Phase 3Completed

Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects

Role: collaborator

NCT07376707Phase 1Recruiting

A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

Role: collaborator

NCT07370909Phase 3Not Yet Recruiting

Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis

Role: collaborator

NCT05885737Phase 3Completed

Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus

Role: collaborator

NCT06666335Phase 4Not Yet Recruiting

A Study to Evaluate Efficacy and Safety of Anakinra in Chinese Patients With Colchicine-resistent FMF

Role: collaborator

NCT02533973Phase 4Completed

Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population

Role: collaborator

NCT05885763Phase 1Completed

Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis

Role: collaborator

NCT06081465Phase 1Recruiting

A Phase I Study of Single and Multiple Doses of VG290131 in Healthy Subjects

Role: collaborator

NCT05388487Phase 1Unknown

Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors

Role: collaborator

NCT05498597Phase 1Unknown

AMT-151 in Patients With Selected Advanced Solid Tumours

Role: collaborator

NCT02761811Not ApplicableActive Not Recruiting

Sympathetic Mapping/ Ablation of Renal Nerves Trial

Role: collaborator

NCT05484466Phase 2Unknown

A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHB

Role: collaborator

NCT03360929Phase 1Completed

Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759

Role: collaborator

NCT05229133Not ApplicableUnknown

Efficacy and Safety of CLEAR in Myopia and Astigmatism in Chinese Population

Role: collaborator

NCT05177926Phase 4Unknown

Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)

Role: collaborator

NCT05172453Unknown

Mother-to-child Transmission of HBV in China

Role: collaborator

NCT03173391Phase 3Completed

Long-term Efficacy and Safety of HMS5552 in T2DM Subjects

Role: collaborator

NCT04952207Unknown

Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C

Role: collaborator